Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

Cited In for PubMed (Select 19363487)

1.

Multiple Mechanisms Contribute To Telomere Maintenance.

Morrish TA, Bekbolysnov D, Velliquette D, Morgan M, Ross B, Wang Y, Chaney B, McQuigg J, Fager N, Maine IP.

J Cancer Biol Res. 2013 Nov 19;1(3). pii: 1012.

2.

Phosphorylation of ribosomal protein S6 confers PARP inhibitor resistance in BRCA1-deficient cancers.

Sun CK, Zhang F, Xiang T, Chen Q, Pandita TK, Huang Y, Hu MC, Yang Q.

Oncotarget. 2014 May 30;5(10):3375-85.

3.

Telomerase enzymatic component hTERT shortens long telomeres in human cells.

Zheng YL, Zhang F, Sun B, Du J, Sun C, Yuan J, Wang Y, Tao L, Kota K, Liu X, Schlegel R, Yang Q.

Cell Cycle. 2014;13(11):1765-76. doi: 10.4161/cc.28705. Epub 2014 Apr 10.

4.

Length-dependent processing of telomeres in the absence of telomerase.

Fallet E, Jolivet P, Soudet J, Lisby M, Gilson E, Teixeira MT.

Nucleic Acids Res. 2014 Apr;42(6):3648-65. doi: 10.1093/nar/gkt1328. Epub 2014 Jan 6.

5.

Complex network analysis of CA3 transcriptome reveals pathogenic and compensatory pathways in refractory temporal lobe epilepsy.

Bando SY, Silva FN, Costa Lda F, Silva AV, Pimentel-Silva LR, Castro LH, Wen HT, Amaro E Jr, Moreira-Filho CA.

PLoS One. 2013 Nov 21;8(11):e79913. doi: 10.1371/journal.pone.0079913. eCollection 2013. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/e9e55996-408c-4660-a0ae-a3597b16f986.

6.

SLX4 assembles a telomere maintenance toolkit by bridging multiple endonucleases with telomeres.

Wan B, Yin J, Horvath K, Sarkar J, Chen Y, Wu J, Wan K, Lu J, Gu P, Yu EY, Lue NF, Chang S, Liu Y, Lei M.

Cell Rep. 2013 Sep 12;4(5):861-9. doi: 10.1016/j.celrep.2013.08.017. Epub 2013 Sep 5.

7.

Localization-dependent and -independent roles of SLX4 in regulating telomeres.

Wilson JS, Tejera AM, Castor D, Toth R, Blasco MA, Rouse J.

Cell Rep. 2013 Sep 12;4(5):853-60. doi: 10.1016/j.celrep.2013.07.033. Epub 2013 Aug 29.

8.

The telomere-associated homeobox-containing protein TAH1/HMBOX1 participates in telomere maintenance in ALT cells.

Feng X, Luo Z, Jiang S, Li F, Han X, Hu Y, Wang D, Zhao Y, Ma W, Liu D, Huang J, Songyang Z.

J Cell Sci. 2013 Sep 1;126(Pt 17):3982-9. doi: 10.1242/jcs.128512. Epub 2013 Jun 26.

9.

Alternative mechanisms of telomere lengthening: permissive mutations, DNA repair proteins and tumorigenic progression.

Gocha AR, Harris J, Groden J.

Mutat Res. 2013 Mar-Apr;743-744:142-50. doi: 10.1016/j.mrfmmm.2012.11.006. Epub 2012 Dec 3. Review.

10.

Long telomeres produced by telomerase-resistant recombination are established from a single source and are subject to extreme sequence scrambling.

Xu J, McEachern MJ.

PLoS Genet. 2012;8(11):e1003017. doi: 10.1371/journal.pgen.1003017. Epub 2012 Nov 1.

11.

Complex chromosomal rearrangements mediated by break-induced replication involve structure-selective endonucleases.

Pardo B, Aguilera A.

PLoS Genet. 2012 Sep;8(9):e1002979. doi: 10.1371/journal.pgen.1002979. Epub 2012 Sep 27.

12.

Arsenic exposure through drinking water is associated with longer telomeres in peripheral blood.

Li H, Engström K, Vahter M, Broberg K.

Chem Res Toxicol. 2012 Nov 19;25(11):2333-9. doi: 10.1021/tx300222t. Epub 2012 Aug 31.

13.

Different expression of alternative lengthening of telomere (ALT)-associated proteins/mRNAs in osteosarcoma cell lines.

Zhang Y, Cai L, Wei RX, Hu H, Jin W, Zhu XB.

Oncol Lett. 2011 Nov;2(6):1327-1332. Epub 2011 Sep 2.

14.

Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.

Lovejoy CA, Li W, Reisenweber S, Thongthip S, Bruno J, de Lange T, De S, Petrini JH, Sung PA, Jasin M, Rosenbluh J, Zwang Y, Weir BA, Hatton C, Ivanova E, Macconaill L, Hanna M, Hahn WC, Lue NF, Reddel RR, Jiao Y, Kinzler K, Vogelstein B, Papadopoulos N, Meeker AK; ALT Starr Cancer Consortium.

PLoS Genet. 2012;8(7):e1002772. Epub 2012 Jul 19.

15.

Akt1 inhibits homologous recombination in Brca1-deficient cells by blocking the Chk1-Rad51 pathway.

Jia Y, Song W, Zhang F, Yan J, Yang Q.

Oncogene. 2013 Apr 11;32(15):1943-9. doi: 10.1038/onc.2012.211. Epub 2012 Jun 4.

17.

PML body meets telomere: the beginning of an ALTernate ending?

Chung I, Osterwald S, Deeg KI, Rippe K.

Nucleus. 2012 May-Jun;3(3):263-75. doi: 10.4161/nucl.20326. Epub 2012 May 1. Review.

18.

Caenorhabditis elegans POT-2 telomere protein represses a mode of alternative lengthening of telomeres with normal telomere lengths.

Cheng C, Shtessel L, Brady MM, Ahmed S.

Proc Natl Acad Sci U S A. 2012 May 15;109(20):7805-10. doi: 10.1073/pnas.1119191109. Epub 2012 Apr 30.

19.

Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer.

Hu J, Hwang SS, Liesa M, Gan B, Sahin E, Jaskelioff M, Ding Z, Ying H, Boutin AT, Zhang H, Johnson S, Ivanova E, Kost-Alimova M, Protopopov A, Wang YA, Shirihai OS, Chin L, DePinho RA.

Cell. 2012 Feb 17;148(4):651-63. doi: 10.1016/j.cell.2011.12.028.

20.

Telomerase-independent paths to immortality in predictable cancer subtypes.

Durant ST.

J Cancer. 2012;3:67-82. doi: 10.7150/jca.3965. Epub 2012 Jan 31.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk